Richard Armstrong

Specialist Property Finding for the Catastrophically Injured. Expert witness reports.

[Richard Armstrong @VisionaryProp]

Here’s a man who knows he will soon be employed by Big Pharma - and also knows his commute won’t change !

#AVCT

[RAH @RAH00084]

#AVCT

[Sandy Radford @sandyradders]

#AVCT

I agree, Tom & Benny.

Long-term investors have funded the scientific progress, but I also think we’re at a tipping point where the AVA6103 data will be compelling and put us even more firmly on pharma companies’ radar. We are entering the cannot be ignored disrupt zone.

Small biotech companies like Avacta, with potentially groundbreaking science, should be protected and nurtured. Shorting small pharma and life science companies should, IMO, be banned. I regard it as an abhorrent form of sabotage.

Regardless of my investment in Avacta, I would still think TW et al are scumbags.

[Richard Armstrong @VisionaryProp]

You were told. Seen this fleecing too many times before. So many geared shareholders taken out just as #AVCT’s second drug is in its golden efficacy zone.

Amazing how gullible some people can be. Fear & greed are powerful tools when the Market Makers use them against you. Avacta is off to the stars.

AVA6103 ‘sure bet’ as per the CEO. Think about the magnitude of that statement.

It will equate into a Biblical bounce

[Richard Armstrong @VisionaryProp]

This is the greatest gift that #avct investors or (dare I say it) traders will ever see.

On the Daily chart the RSI is down to 19.7 - last time it hit this level the stock bounced 50% in no time.

Bookmark this tweet - this time will be no different

[Richard Armstrong @VisionaryProp]

@Gear_Tales @dabeeches Obviously knew in his heart of hearts he was a cretin. Bless 🙌

[Richard Armstrong @VisionaryProp]

Every single time the mass trolling and FUD stops with #Avct you know that a reversal is coming.

As predictable as night follows day - and all (like the last times) totally orchestrated.

The Directors happily paid up for a million shares at 68p - at this level here's your Christmas present. So much to be announced in the next weeks.

And never forget - the data which is rolling right now will dictate the value of ALL the deals on the table.

[Richard Armstrong @VisionaryProp]

@Gear_Tales @dabeeches Arguing with the unresearched about Avacta is like playing chess with a pidgeon. Whatever you say or do it'll still strut round the board dropping shit and pretending it's won

[Richard Armstrong @VisionaryProp]

@Gear_Tales @dabeeches

[All about Steve @1StevieKilner]

The man who invented Benylin was buried last week.
As a mark of respect there was no coffin at his funeral.

[Richard Armstrong @VisionaryProp]

Happy to report that after day after day of huge shapes in the auctions the uncrossing trade was at 54p on volume of 18,647 shares

SHENANIGANS complete

52p was the low today

Any bets on the pre Christmas-high? #avct #firsttimeinalongtime #Trendreversal

[Richard Armstrong @VisionaryProp]

@dabeeches Let me know your address and I'll get you some crayons for Christmas

[MM @emily1katie]

As I digest the millionth opinion on #AVCT I am reminded (Stanley Druckenmiller) the best way to make obscene amounts of money is buying an idea which is not popular today but what will be popular tomorrow.

AVA6103 is the on cusp of that revolution.

Churning out data - right now - which will define how toxic chemotherapies are delivered safely tomorrow.

I don’t think even the staunchest advocates realise the magnitude of what AVCT is sat on right now in AVA6103:

“A remarkable alignment of pre-clinical and clinical data”

“The best (Coughlin) has seen in over two decades”

A “sure bet”.

It works. Enormous value is inevitable if you can detach from the artificial noise.

[Richard Armstrong @VisionaryProp]

We are all entitled to to an opinion but it is better if you try and work it on facts.

The all time low was about 15 pence in 2019

So we are approx 335% ABOVE the all time low. Which isn’t “near”

The market is also probably telling the rest of us something different - the reversal is in and losses has 3 s’s in my world not 2

#Avct
#Christmaspresentpricing

[Miss Ally @MissAlly_01]

I reckon Guy Fawkes plan to blow up Parliament on November 5th was kind of genius because people wouldn't notice the explosions, what with all the fireworks going off & all.

[Richard Armstrong @VisionaryProp]

@markTHFC82 Simple. Stop the DD and pay as you use. Be very rude if they tell you you cannot do that. It’s appalling but that’s rip off Britain

[Richard Armstrong @VisionaryProp]

@tom_the_bomb__ Nor for much longer - this is the shorter's last hurrah! #avct

[Richard Armstrong @VisionaryProp]

This is the greatest gift that #avct investors or (dare I say it) traders will ever see.

On the Daily chart the RSI is down to 19.7 - last time it hit this level the stock bounced 50% in no time.

Bookmark this tweet - this time will be no different

[Richard Armstrong @VisionaryProp]

@RoryStuart15 @w82497 And what will his 16 followers read ?

[Richard Armstrong @VisionaryProp]

@mmmmcrisps @JeffreyGreaves1 @EE Why thank you - I'm sure your 3 followers will be excited to read your drivel!

[Richard Armstrong @VisionaryProp]

@AndrewDigby3 I think they're done Andrew

[Richard Armstrong @VisionaryProp]

Myles absolutely hitting all the nails on the head here ........#AVCT

[Myles McNulty @MylesMcNulty]

Regardless of whether it was a determined seller or a short that has dragged #AVCT down in recent weeks, I think these numerous big prints at 55/56p mark the bottom of this mad selloff.

I'm sure very many are watching closely (like me!) for any further big prints today, and are beginning to scale (more) in for a strong recovery from the current 9-month low share price.

We had a £12m cash injection at a (then) discounted 68p less than 4 weeks ago. Cash runway extends to May next year, and gross debt is now a negligible <£10m.

We're highly likely to see some form of partnership for the first Gen3 asset, AVA6207, before Christmas (given the ATRi reveal in 14 days' time); as well as another form of partnership for AVA6000 - in my view again before Christmas - to fund it through the pivotal Phase 2 trial.

Do they partner 6103 this early on? I would hope not, unless it's for a very narrow scope (a single indication in a single region) and for a monster upfront cash sum ($100m+).

Despite what the SP currently portrays, Avacta continues to make gargantuan strides. But we continue to suffer from a surreal blend of PTSD (caused by dramatic volatility over the past six years), and a case of a too-good-to-be-true story. And, of course, overleveraged players getting spanked every few months by the aforementioned volatility!

Ignore the noise and volatility, and appreciate that Avacta is doing remarkanble work in the battle against cancer.

A multi-billion-$ for shareholders is, in my eyes, more likely than ever before.